e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Community- and hospital-acquired pneumonias: inflammatory mechanisms, epidemiology and therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Legionnaires' disease: diagnostic and therapeutic features about 31 cases
G. Brunin, P. Ducq, R. Pordes (Boulogne Sur Mer, France)
Source:
Annual Congress 2002 - Community- and hospital-acquired pneumonias: inflammatory mechanisms, epidemiology and therapy
Session:
Community- and hospital-acquired pneumonias: inflammatory mechanisms, epidemiology and therapy
Session type:
Poster Discussion
Number:
2671
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Brunin, P. Ducq, R. Pordes (Boulogne Sur Mer, France). Legionnaires' disease: diagnostic and therapeutic features about 31 cases. Eur Respir J 2002; 20: Suppl. 38, 2671
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Diagnostic approach to environmental/occupational pulmonary disease; how to differentiate from 'idiopathic' lung disease
Source: Annual Congress 2004 - PG10 - Occupational and environmental disorders of the lung parenchyma
Year: 2004
A small outbreak of Legionnaires' disease in a cargo ship under repair
Source: Eur Respir J 2001; 17: 1322-1327
Year: 2001
Unclassified or unclassifiable interstitial lung disease: confusing or helpful disease category?
Source: Eur Respir J 2013; 42: 576-579
Year: 2013
Lung-limited IgG4-related disease: A new form of IgG4-related disease?
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012
Interstitial pneumonia with autoimmune features: applying novel diagnostic criteria to an existing patient cohort.
Source: International Congress 2017 – Novel and old entities
Year: 2017
Amyloid-and nonamyloid-deposition disease in the lung: novel manifestations
Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans
Year: 2013
IPF - The patients' differential diagnosis of COPD
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year:
Invasive procedures and etiological diagnosis in severe pneumonia: A case study of 20 patients
Source: Eur Respir J 2003; 22: Suppl. 45, 544s
Year: 2003
Eosinophilic lung disease: clinical features of 25 patients
Source: Eur Respir J 2006; 28: Suppl. 50, 237s
Year: 2006
Validation of an etiological diagnostic model in adults with a diagnosis of bronchiectasis.
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Non CF-bronchiectasis in Greece: aetiologic approach, clinical and microbioligal profile of 115 cases
Source: Eur Respir J 2004; 24: Suppl. 48, 638s
Year: 2004
The smellprint of mesothelioma cells: intrinsic biomarkers for diagnosis and subtyping
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020
New radiological diagnostic criteria: impact on idiopathic pulmonary fibrosis diagnosis
Source: Eur Respir J, 54 (5) 1900905; 10.1183/13993003.00905-2019
Year: 2019
Stricter microbiological criteria are useful surrogate in estimating the prevalence of nontuberculous mycobacterial pulmonary disease in Croatia
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Monitoring disease progression in patients with biopsy proven cases of sarcoidosis: A survey
Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside
Year: 2010
Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened
Source: Eur Respir J 2016; 47: 1293-1295
Year: 2016
Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies?
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened
Source: Eur Respir J 2016; 47: 1295-1296
Year: 2016
The diagnostic meaning of clinical-epidemiological signs among MDR TB patients
Source: Eur Respir J 2006; 28: Suppl. 50, 378s
Year: 2006
Clinical presentation of Legionnaires’ disease during an outbreak: The typical presentation of an atypical pathogen
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept